News | Respiratory tract diseases

Opinion

SARS-CoV2 antivirals are essential, but they are not silver bullets

The UK government's 'living with COVID-19' policy is relying too much on antiviral treatments, but now is not the time to relax.…

Published: 22 June 2022

News

More than a quarter of patients overusing rescue inhalers for asthma, study finds 

Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…

Published: 20 June 2022

News

Paxlovid more effective in older, vaccinated COVID-19 patients, research shows 

Researchers looked at data for more than 180,000 patients in Israel who had tested positive for COVID-19.…

Published: 8 June 2022

News

Metered-dose inhaler classed as ‘carbon neutral’ through offsetting

Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…

Published: 25 May 2022

News

MHRA receives Yellow Card reports of viral rebound in people treated with Paxlovid

Exclusive: The Medicines and Healthcare products Regulatory Agency said the number of reports aligned with that seen in Paxlovid clinical trials.…

Published: 25 May 2022

Feature

Post-Paxlovid viral rebound – what do we know and should we be worried?

With reports of sudden viral rebound in patients days after completing the treatment regimen for the antiviral Paxlovid, we take a look at what this may mean for our protection against COVID-19.…

Published: 25 May 2022

News

Prescribing of antibiotics in young children at highest levels in five years

Data show that rates of antibiotic prescribing in children aged 0–4 years are the highest they have been since December 2017.…

Published: 16 May 2022

News

Government to assess efficacy of Evusheld against Omicron variant before buying stock

Exclusive: The UK Health Security Agency is conducting tests to ascertain pre-exposure prophylaxis treatment Evusheld's effectiveness and length of protection against both BA.1 and BA.2 subvariants of COVID-19.…

Published: 11 May 2022

News

Thousands receive COVID-19 monoclonal antibody despite efficacy concerns

Exclusive: Some experts have warned that the continued use of sotrovimab is “inappropriate”, owing to its low efficacy against the dominant BA.2 variant in the UK.…

Published: 22 April 2022

Feature

Spilling the beans on the health impacts of coffee

On average, 98 million cups of coffee are consumed each day in the UK. Is this popular drink harmful or do its benefits outweigh its risks?…

Published: 14 April 2022